Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

74 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Strategies to simplify complex medication regimens.
Bell JS, McInerney B, Chen EY, Bergen PJ, Reynolds L, Sluggett JK. Bell JS, et al. Among authors: bergen pj. Aust J Gen Pract. 2021 Jan-Feb;50(1-2):43-48. doi: 10.31128/AJGP-04-20-5322. Aust J Gen Pract. 2021. PMID: 33543163 Free article.
Safe disposal of prescribed medicines.
Bergen PJ, Hussainy SY, George J, Kong DC, Kirkpatrick CM. Bergen PJ, et al. Aust Prescr. 2015 Jun;38(3):90-2. doi: 10.18773/austprescr.2015.031. Epub 2015 Jun 1. Aust Prescr. 2015. PMID: 26648628 Free PMC article. Review.
Clinically relevant concentrations of fosfomycin combined with polymyxin B, tobramycin or ciprofloxacin enhance bacterial killing of Pseudomonas aeruginosa, but do not suppress the emergence of fosfomycin resistance.
Walsh CC, Landersdorfer CB, McIntosh MP, Peleg AY, Hirsch EB, Kirkpatrick CM, Bergen PJ. Walsh CC, et al. Among authors: bergen pj. J Antimicrob Chemother. 2016 Aug;71(8):2218-29. doi: 10.1093/jac/dkw115. Epub 2016 Apr 26. J Antimicrob Chemother. 2016. PMID: 27118778
Effect of different renal function on antibacterial effects of piperacillin against Pseudomonas aeruginosa evaluated via the hollow-fibre infection model and mechanism-based modelling.
Bergen PJ, Bulitta JB, Kirkpatrick CM, Rogers KE, McGregor MJ, Wallis SC, Paterson DL, Lipman J, Roberts JA, Landersdorfer CB. Bergen PJ, et al. J Antimicrob Chemother. 2016 Sep;71(9):2509-20. doi: 10.1093/jac/dkw153. Epub 2016 May 26. J Antimicrob Chemother. 2016. PMID: 27231278
Substantial Impact of Altered Pharmacokinetics in Critically Ill Patients on the Antibacterial Effects of Meropenem Evaluated via the Dynamic Hollow-Fiber Infection Model.
Bergen PJ, Bulitta JB, Kirkpatrick CMJ, Rogers KE, McGregor MJ, Wallis SC, Paterson DL, Nation RL, Lipman J, Roberts JA, Landersdorfer CB. Bergen PJ, et al. Antimicrob Agents Chemother. 2017 Apr 24;61(5):e02642-16. doi: 10.1128/AAC.02642-16. Print 2017 May. Antimicrob Agents Chemother. 2017. PMID: 28264846 Free PMC article.
Differences in suppression of regrowth and resistance despite similar initial bacterial killing for meropenem and piperacillin/tazobactam against Pseudomonas aeruginosa and Escherichia coli.
Bergen PJ, Bulitta JB, Sime FB, Lipman J, McGregor MJ, Millen N, Paterson DL, Kirkpatrick CMJ, Roberts JA, Landersdorfer CB. Bergen PJ, et al. Diagn Microbiol Infect Dis. 2018 May;91(1):69-76. doi: 10.1016/j.diagmicrobio.2017.12.019. Epub 2018 Jan 3. Diagn Microbiol Infect Dis. 2018. PMID: 29395712
Optimization and Evaluation of Piperacillin-Tobramycin Combination Dosage Regimens against Pseudomonas aeruginosa for Patients with Altered Pharmacokinetics via the Hollow-Fiber Infection Model and Mechanism-Based Modeling.
Yadav R, Rogers KE, Bergen PJ, Bulitta JB, Kirkpatrick CMJ, Wallis SC, Paterson DL, Nation RL, Lipman J, Roberts JA, Landersdorfer CB. Yadav R, et al. Among authors: bergen pj. Antimicrob Agents Chemother. 2018 Apr 26;62(5):e00078-18. doi: 10.1128/AAC.00078-18. Print 2018 May. Antimicrob Agents Chemother. 2018. PMID: 29463528 Free PMC article.
Meropenem-Tobramycin Combination Regimens Combat Carbapenem-Resistant Pseudomonas aeruginosa in the Hollow-Fiber Infection Model Simulating Augmented Renal Clearance in Critically Ill Patients.
Yadav R, Bergen PJ, Rogers KE, Kirkpatrick CMJ, Wallis SC, Huang Y, Bulitta JB, Paterson DL, Lipman J, Nation RL, Roberts JA, Landersdorfer CB. Yadav R, et al. Among authors: bergen pj. Antimicrob Agents Chemother. 2019 Dec 20;64(1):e01679-19. doi: 10.1128/AAC.01679-19. Print 2019 Dec 20. Antimicrob Agents Chemother. 2019. PMID: 31636062 Free PMC article.
Evaluation of Meropenem-Ciprofloxacin Combination Dosage Regimens for the Pharmacokinetics of Critically Ill Patients With Augmented Renal Clearance.
Agyeman AA, Rogers KE, Tait JR, Bergen PJ, Kirkpatrick CM, Wallis SC, Bulitta JB, Paterson DL, Lipman J, Nation RL, Roberts JA, Landersdorfer CB. Agyeman AA, et al. Among authors: bergen pj. Clin Pharmacol Ther. 2021 Apr;109(4):1104-1115. doi: 10.1002/cpt.2191. Epub 2021 Mar 12. Clin Pharmacol Ther. 2021. PMID: 33550617
74 results